HomePrograms ▶ Unrestricted Grants
Unrestricted Grants

Important Notes

Applicants are strongly advised to read the instructions and eligibility criteria before starting an application.
Letters of Intent (LOI) are available on the Foundant Technologies Website.
Invitations to submit a full application will be sent in October 2020. You must be invited to submit a full application.


Anticipated Timeline

June 1, 2020 Letter of Intent Period Opens
September 8, 2020 Deadline for Letter of Intent due by 11:59 pm Eastern Time
October 2020 Invitation from Scientific Advisory Committee for Full Applications
December 1, 2020 Full Application Deadline due by 11:59 pm Eastern Time
January 2021 Grantee Notification
February 2021 Grant Start Date


Unrestricted Research Grant Opportunities

17 grants available
$40,000 for 1 year

Target audience:
Investigators interested in basic science, translational, or clinical research in pulmonary, critical care, and sleep medicine

The focus of these research grants is to support junior investigators interested in research that advances the knowledge and understanding of the three pillars of the ATS: pulmonary, critical care, and sleep medicine. A primary goal of the ATS Research Program is to enable junior investigators the chance to make the transition to careers as established investigators.

The Research Program encourages international and domestic applications in basic, patient-oriented, and public health topics. In the area of public health, the Research Program is particularly interested in funding projects that will inform health policy decisions. These include projects that explore the quality and safety of a specific treatment and compare the effectiveness of different therapies. 

The ATS Research Program will award up to seventeen unrestricted research grants for $40,000 for one year for salaries, supplies, or a combination of these two. Indirect costs will not be paid to the sponsoring institution. The Research Program will award two grants to the top scores in each of the three society pillars: pulmonary, critical care, and sleep.* The remaining grants will be awarded to the top scores regardless of the category of submission. 

Award-specific eligibility:
• Junior investigators (as defined here)
• Must meet eligibility requirements for all grants found here

*While it is intended that there be two awards in each pillar (pulmonary, critical care, and sleep medicine), the ATS Scientific Advisory Committee reserves the right to alter this distribution dependent upon the significant scientific merit of applications.

Review Process

Please note that after you submit your application it will be reviewed by Research Program staff. If there are any problems or if these guidelines have not been followed, your proposal will be un-submitted. Please make sure that you check your email after you submit your application so that any outstanding issues may be addressed as quickly as possible.

The ATS Scientific Advisory Committee (SAC) will review the applications in January 2021. The membership of the SAC is listed on the ATS Website and additional ad hoc reviewers will be invited to participate as needed. Funding decisions will be made on the basis of scientific merit, novelty, and responsiveness to the purpose of the specific grant program.

ATS Policy on Additional Grant Funding

Simultaneous submission of grants with scientific overlap is allowed, but if multiple applications are funded, then the applicant must notify the Research Program within one month of formal notification of award. A subcommittee of the SAC will assess the degree of overlap. In the case of significant scientific overlap, the applicant will have to choose between the ATS research grant and the other grant. Budgetary overlap is not allowed.

If your question is not answered in the FAQ, contact the ATS Research Program at

The American Thoracic Society improves global health by advancing research, patient care, and public health in pulmonary disease, critical illness, and sleep disorders. Founded in 1905 to combat TB, the ATS has grown to tackle asthma, COPD, lung cancer, sepsis, acute respiratory distress, and sleep apnea, among other diseases.

Twitter Facebook LinkedIn Instagram YouTube Social Media Page

25 Broadway
New York, NY 10004
United States of America

Phone: +1 (212) 315-8600
Fax: +1 (212) 315-6498

© 1998 - American Thoracic Society, all rights reserved.